Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	243 Pages	Coherent Market Insights	May, 2022	CMI17213000

Best Price Guarantee
Price	from $4,500
Length	243 Pages
Publisher	Coherent Market Insights
Published Date	May, 2022
SKU	CMI17213000

Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Pain management is a broad branch of medical science that utilizes an interdisciplinary approach to easing the patient's suffering and enhancing the quality of life of patients with chronic pain. A common aim of pain management is reducing the use of narcotics or pain killers, relaxing the patients' lifestyle and providing education on stress and pain management. The use of pain management treatments in combination with a holistic approach to disease prevention and therapy is now recognized as an effective treatment approach for moderate to severe pain. Chronic pain can result from injury, disease or injury, or be the result of a disease such as cancer or Parkinson's disease.
Market Dynamics:
R&D of new therapeutics is expected to propel growth of the global pain management therapeutics market over the forecast period. For instance, in August 2021, Flexion Therapeutics, Inc. expanded the placebo-controlled trial of FX301, a novel formulation of a locally administered NaV1.7 inhibitor (funapide) which aims to provide at least three to five days of post-operative pain relief while preserving motor function, in patients undergoing bunionectomy.
Moreover, increasing number of pain management clinics is also expected to aid in growth of the market. For instance, in August 2021, QC Kinetix, a regenerative medicine company that offers a non-surgical alternative to pain relief, started a new location Birmingham.
Key features of the study:
This report provides in-depth analysis of the global pain management therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AcelRx Pharmaceuticals, Inc. Averitas Pharma, Inc., AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, Teva Pharmaceuticals, Abbott Laboratories, Allergan, Inc., Covidien plc, Durect Corporation, Eli Lilly and Company, Endo Health Solutions, Inc., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc., Mundipharma International Ltd., and Novartis International AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management therapeutics market
Detailed Segmentation:
Global Pain Management Therapeutics Market, By Pain Type:
Chronic
Acute
Global Pain Management Therapeutics Market, By Drug Class:
NSAIDS
Anesthetics
Global Pain Management Therapeutics Market, By Region:
North America
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
U.S.
Canada
Latin America
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Pain Type
Chronic
Acute
By Drug Class
NSAIDS
Anesthetics
Anticonvulsant
Anti-migraine Drugs
Antidepressant Drugs
Opioids
Non-narcotics
Analgesics
By Indication
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Pain
Post-operative Pain
Migraine
Fibromyalgia
Bone Fracture
Muscle Sprain/Strain
Acute Appendicitis
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
AcelRx Pharmaceuticals, Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Averitas Pharma, Inc.
AmerisourceBergen
Cardinal Health
McKesson Corporation
Johnson & Johnson
Teva Pharmaceuticals
Abbott Laboratories
Allergan, Inc
Covidien plc
Durect Corporation
Eli Lilly and Company
Endo Health Solutions, Inc
Forest Laboratories, Inc.
GlaxoSmithKline plc
Hospira, Inc.
Merck & Co., Inc
Mundipharma International Ltd.
Novartis International AG
“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snippet, By Pain Type; Market Snippet, By Drug Class; Market Snippet, By Indication; Market Snippet, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Key Highlights; Product launch; Regulatory Scenario; PEST Analysis; Mergers and Acquisitions
4. Global Pain Management Therapeutics Market, By Pain Type, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Chronic; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Acute; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Pain Management Therapeutics Market, By Drug Class, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; NSAIDS; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Anesthetics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Anticonvulsant; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Anti-migraine Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Antidepressant Drugs; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Opioids; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Non-narcotics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Analgesics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Pain Management Therapeutics Market, By Indication, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Arthritic Pain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Neuropathic Pain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Cancer Pain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Chronic Pain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Post-operative Pain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Migraine; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Fibromyalgia; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Bone Fracture; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Muscle Sprain/Strain; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Acute Appendicitis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Pain Management Therapeutics Market, By Region, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, By Region, 2022 and 2028 (%); Y-o-Y Growth Analysis, For Regions, 2017 - 2028; North America; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); U.S.; Canada; Latin America; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); Germany; U.K.; France; Italy; Spain; Russia; Rest of Europe; Asia Pacific; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); China; India; Japan; Australia; South Korea; ASEAN; Rest of APAC; Middle East; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Market Size and Forecast, By Pain Type, 2017 - 2028, (US$ Million); Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million); Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million); Market Size and Forecast, By Country, 2017 - 2028, (US$ Million); South Africa; Central Africa; North Africa
8. Competitive Landscape: Company Profiles; AcelRx Pharmaceuticals, Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Averitas Pharma, Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; AmerisourceBergen; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Cardinal Health; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; McKesson Corporation; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Johnson & Johnson; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Teva Pharmaceuticals; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Abbott Laboratories; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Allergan, Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Covidien plc; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Durect Corporation; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Eli Lilly and Company; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Endo Health Solutions, Inc; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Forest Laboratories, Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; GlaxoSmithKline plc; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Hospira, Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Merck & Co., Inc.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Mundipharma International Ltd.; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies; Novartis International AG; Company Overview; Product Portfolio; Financial Overview; Key Highlights; Market Strategies
9. Section: References; Research Methodology; About us and Sales Contact; *Browse 36 market data tables and 34 figures on “Pain Management Therapeutics Market - Global forecast to 2028”.

Pain Management Drugs Market Size, Trends, Analysis, and Outlook By Type (Chronic pain, Acute pain), By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Others), by Region, Country, Segment, and Companies, 2024-2030

March, 2024 | Published by: VPA Research | USD $3,980
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033

July, 2024 | Published by: Allied Market Research | USD $5,769
Chronic Pain Market, by Drug (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, Others), by Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia and Others), by Appli

May, 2022 | Published by: Coherent Market Insights | USD $4,500
Pain Management Therapeutics Market (Therapeutics: Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Antimigraine Agents, and Other Non-narcotic Analgesics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

October, 2022 | Published by: Transparency Market Research Pvt. Ltd. | USD $5,795
Pain Management Drugs Market Size - By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine), Indication (Arthritic, Neuropathic, Cancer), Pain Type (Chronic, Acute), Distribution Channel (Hospital, Retail, Online), Global Forecast (2023 - 2032)

July, 2023 | Published by: Global Market Insights | USD $5,150
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

March, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899

PDF E-mail From Publisher:	$4,500
Site License Fulfilled by Publisher:	$7,000
Global Site License Fulfilled by Publisher:	$10,000

Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer

Research Assistance

Other tasks

Pain Management Therapeutics Market, By Pain Type (Chronic, Acute), By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer

Chronic Pain Market, by Drug (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, Others), by Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia and Others), by Appli

Pain Management Therapeutics Market (Therapeutics: Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Antimigraine Agents, and Other Non-narcotic Analgesics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Pain Management Drugs Market Size - By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine), Indication (Arthritic, Neuropathic, Cancer), Pain Type (Chronic, Acute), Distribution Channel (Hospital, Retail, Online), Global Forecast (2023 - 2032)

Research Assistance

Other tasks